148 related articles for article (PubMed ID: 11418632)
21. CD28 co-stimulation results in down-regulation of lymphotactin expression in human CD4(+) but not CD8(+) T cells via an IL-2-dependent mechanism.
Olive D; Cerdan C
Eur J Immunol; 1999 Aug; 29(8):2443-53. PubMed ID: 10458758
[TBL] [Abstract][Full Text] [Related]
22. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models.
Emtage PC; Wan Y; Hitt M; Graham FL; Muller WJ; Zlotnik A; Gauldie J
Hum Gene Ther; 1999 Mar; 10(5):697-709. PubMed ID: 10210138
[TBL] [Abstract][Full Text] [Related]
23. CD8+ alpha beta+ T cells that lack surface CD5 antigen expression are a major lymphotactin (XCL1) source in peripheral blood lymphocytes.
Stievano L; Tosello V; Marcato N; Rosato A; Sebelin A; Chieco-Bianchi L; Amadori A
J Immunol; 2003 Nov; 171(9):4528-38. PubMed ID: 14568926
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X
J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740
[TBL] [Abstract][Full Text] [Related]
25. Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia.
Boismenu R; Feng L; Xia YY; Chang JC; Havran WL
J Immunol; 1996 Aug; 157(3):985-92. PubMed ID: 8757601
[TBL] [Abstract][Full Text] [Related]
26. Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease.
Middel P; Thelen P; Blaschke S; Polzien F; Reich K; Blaschke V; Wrede A; Hummel KM; Gunawan B; Radzun HJ
Am J Pathol; 2001 Nov; 159(5):1751-61. PubMed ID: 11696436
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma.
Ju DW; Tao Q; Cheng DS; Zhang W; Zhang M; Hamada H; Cao X
Gene Ther; 2000 Feb; 7(4):329-38. PubMed ID: 10694814
[TBL] [Abstract][Full Text] [Related]
28. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
Zhang W; He L; Cao X
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
[TBL] [Abstract][Full Text] [Related]
29. Helper-independent, L-selectinlow CD8+ T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression.
Peng L; Kjaergaard J; Plautz GE; Weng DE; Shu S; Cohen PA
J Immunol; 2000 Nov; 165(10):5738-49. PubMed ID: 11067932
[TBL] [Abstract][Full Text] [Related]
30. Regression of engineered myeloma cells secreting interferon-gamma-inducing factor is mediated by both CD4(+)/CD8(+) T and natural killer cells.
Xiang J; Chen Z; Huang H; Moyana T
Leuk Res; 2001 Oct; 25(10):909-15. PubMed ID: 11532525
[TBL] [Abstract][Full Text] [Related]
31. Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection.
Wang JD; Nonomura N; Takahara S; Li BS; Azuma H; Ichimaru N; Kokado Y; Matsumiya K; Miki T; Suzuki S; Okuyama A
Immunology; 1998 Sep; 95(1):56-61. PubMed ID: 9767457
[TBL] [Abstract][Full Text] [Related]
32. Identification of a chicken "C" chemokine related to lymphotactin.
Rossi D; Sanchez-García J; McCormack WT; Bazan JF; Zlotnik A
J Leukoc Biol; 1999 Jan; 65(1):87-93. PubMed ID: 9886250
[TBL] [Abstract][Full Text] [Related]
33. Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.
Zhang J; Zhou Z; Wang C; Shen J; Zheng Y; Zhang L; Wang J; Xia D
Cancer Immunol Immunother; 2011 Apr; 60(4):559-73. PubMed ID: 21240488
[TBL] [Abstract][Full Text] [Related]
34. Migratory response of human natural killer cells to lymphotactin.
Giancarlo B; Silvano S; Albert Z; Mantovani A; Allavena P
Eur J Immunol; 1996 Dec; 26(12):3238-41. PubMed ID: 8977329
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
Wright P; Zheng C; Moyana T; Xiang J
Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
[TBL] [Abstract][Full Text] [Related]
36. Lymphotactin: a new class of chemokine.
Hedrick JA; Zlotnik A
Methods Enzymol; 1997; 287():206-15. PubMed ID: 9330324
[No Abstract] [Full Text] [Related]
37. Transgenic expression of Ly49A on T cells impairs a specific antitumor response.
Brawand P; Lemonnier FA; MacDonald HR; Cerottini JC; Held W
J Immunol; 2000 Aug; 165(4):1871-6. PubMed ID: 10925266
[TBL] [Abstract][Full Text] [Related]
38. Expression of lymphotactin mRNA in experimental crescentic glomerulonephritis.
Natori Y; Ou ZL; Yamamoto-Shuda Y; Natori Y
Clin Exp Immunol; 1998 Aug; 113(2):265-8. PubMed ID: 9717977
[TBL] [Abstract][Full Text] [Related]
39. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor.
Fioretti F; Fradelizi D; Stoppacciaro A; Ramponi S; Ruco L; Minty A; Sozzani S; Garlanda C; Vecchi A; Mantovani A
J Immunol; 1998 Jul; 161(1):342-6. PubMed ID: 9647242
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
